These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 1576382)

  • 1. Mitomycin-induced pulmonary toxicity: case report and review of the literature.
    Linette DC; McGee KH; McFarland JA
    Ann Pharmacother; 1992 Apr; 26(4):481-4. PubMed ID: 1576382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Syndrome of acute dyspnea related to combined mitomycin plus vinca alkaloid chemotherapy.
    Rivera MP; Kris MG; Gralla RJ; White DA
    Am J Clin Oncol; 1995 Jun; 18(3):245-50. PubMed ID: 7747713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MVP (mitomycin, vinblastine, and progesterone): a second-line regimen in ovarian cancer with a high incidence of pulmonary toxicity.
    Ozols RF; Hogan WM; Ostchega Y; Young RC
    Cancer Treat Rep; 1983; 67(7-8):721-2. PubMed ID: 6871888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Acute bronchospasm due to periwinkle alkaloid and mitomycin association].
    Thomas P; Pradal M; Le Caer H; Montcharmont D; Vervloet D; Kleisbauer JP
    Rev Mal Respir; 1993; 10(3):268-70. PubMed ID: 8346375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pulmonary toxicity of mitomycin.
    Buzdar AU; Legha SS; Luna MA; Tashima CK; Hortobagyi GN; Blumenschein GR
    Cancer; 1980 Jan; 45(2):236-44. PubMed ID: 7351010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitomycin C-induced hemolytic uremic syndrome. Six case reports and review of the literature on renal, pulmonary and cardiac side effects of the drug.
    Verweij J; van der Burg ME; Pinedo HM
    Radiother Oncol; 1987 Jan; 8(1):33-41. PubMed ID: 3101142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. KW-2149-induced pulmonary toxicity is not prevented by corticosteroids: a phase I and pharmacokinetic study.
    Schrijvers D; Catimel G; Highley M; Höppener FJ; Dirix L; De Bruijn E; Droz JP; Van Oosterom AT
    Anticancer Drugs; 1999 Aug; 10(7):633-9. PubMed ID: 10507312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitomycin lung toxicity. Acute and chronic phases.
    Okuno SH; Frytak S
    Am J Clin Oncol; 1997 Jun; 20(3):282-4. PubMed ID: 9167754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospective study on the dose relationship of mitomycin C-induced interstitial pneumonitis.
    Verweij J; van Zanten T; Souren T; Golding R; Pinedo HM
    Cancer; 1987 Aug; 60(4):756-61. PubMed ID: 3109726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Lung parenchyma disease following instillation of mitomycin C in the bladder].
    Wilhelms E; Criée CP; Neubauer H; Neuhaus KL
    Dtsch Med Wochenschr; 1986 Oct; 111(41):1564-6. PubMed ID: 3095083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Case report: topical DMSO for mitomycin-C-induced skin ulceration.
    Alberts DS; Dorr RT
    Oncol Nurs Forum; 1991; 18(4):693-5. PubMed ID: 1906166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Experimental and clinical data of the pulmonary toxicity of mitomycin C].
    Gatzemeier U; Fasske E; Nowak U
    Pneumologie; 1990 Feb; 44 Suppl 1():201-3. PubMed ID: 2114625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of advanced breast cancer with mitomycin C combined with vinblastine or vindesine.
    Garewal HS; Brooks RJ; Jones SE; Miller TP
    J Clin Oncol; 1983 Dec; 1(12):772-5. PubMed ID: 6422004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isoniazid-associated psychosis: case report and review of the literature.
    Pallone KA; Goldman MP; Fuller MA
    Ann Pharmacother; 1993 Feb; 27(2):167-70. PubMed ID: 8439690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dyspnea following vinblastine or vindesine administration in patients receiving mitomycin plus vinca alkaloid combination therapy.
    Kris MG; Pablo D; Gralla RJ; Burke MT; Prestifilippo J; Lewin D
    Cancer Treat Rep; 1984; 68(7-8):1029-31. PubMed ID: 6744336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Acute dyspnea following intravenous administration of vinblastine/mitomycin C].
    Lagler U; Gattiker HH
    Schweiz Med Wochenschr; 1989 Mar; 119(9):290-2. PubMed ID: 2496465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitomycin C-induced renal toxicity, a dose-dependent side effect?
    Verwey J; de Vries J; Pinedo HM
    Eur J Cancer Clin Oncol; 1987 Feb; 23(2):195-9. PubMed ID: 3127216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase II study of 7-N-(p-hydroxyphenyl)-mitomycin C (KW2083) in patients with advanced non-small cell carcinoma of the lung and metastatic pulmonary tumors.
    Shinkai T; Saijo N; Tominaga K; Eguchi K; Shimizu E; Sasaki Y; Fujita J; Futami H; Hoshi A
    Jpn J Clin Oncol; 1985 Mar; 15(1):61-5. PubMed ID: 3981815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pulmonary angiomatoid vascular changes in mitomycin C-associated hemolytic-uremic syndrome.
    Chang-Poon VY; Hwang WS; Wong A; Berry J; Klassen J; Poon MC
    Arch Pathol Lab Med; 1985 Sep; 109(9):877-8. PubMed ID: 3927871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pulmonary toxicity induced by mitomycin C is highly responsive to glucocorticoids.
    Chang AY; Kuebler JP; Pandya KJ; Israel RH; Marshall BC; Tormey DC
    Cancer; 1986 Jun; 57(12):2285-90. PubMed ID: 3084059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.